Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patients

International Immunopharmacology

Volumn 3, Issue 9, 2003, Pages 1257-1260

  Gürer, Ümran Soyoǧul ^a   Büyüköztürk, Suna ^b   Palandüz, Şükrü ^b   Gürbüz, Burçak ^a   Çevikbaş, Adile ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Allergic inflammation; Asthma; Montelukast; Polymorphonuclear leukocytes

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST;

ADULT; ALLERGIC ASTHMA; ARTICLE; BLOOD SAMPLING; CELL ACTIVITY; CELL FUNCTION; CELL ISOLATION; CELL KILLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HUMAN; HUMAN CELL; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 18344407900     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00043-2     Document Type: Article

References (32)

1. Handerson W.R. Jr., Tang L.O., Chu S.J., Tsao S.M., Chiang G.K., Jones F.et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165(1):2002;108-116.
2. Thien F. Leukotriene antagonists. Do they offer new hope for asthmatics? Aust. Fam. Physician. 29(6):2000;547-551.
3. Garcia-Marcos L., Schuster A. Antileukotrienes in asthma: present situation. Expert Opin. Pharmacother. 2(3):2001;441-466.
4. Williams B., Noonan G., Reis T.F., Knorr B., Guerra J., White R.et al. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin. Exp. Allergy. 31(6):2001;845-854.
5. Wilson A.M., Dempsey O.J., Sims E.J., Lipworth B.J. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids. Chest. 119(4):2001;1021-1026.
6. Malmstrom K., Rodriguaez-Gomez G., Guerra J., Villaran C., Pineiro A., Wei L.X.et al. Oral montelukast, inhaled beclomethasone and placebo for chronic asthma. A randomized, controlled trial Montelukast/Beclomethasone Study Group. Ann. Intern. Med. 130(6):1999;487-495.
7. Altman L.C., Munk Z., Seltzer J., Noonan N., Shingo S.et al. A placebo controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. J. Allergy Clin. Immunol. 102(1):1998;50-56.
8. Minoguchi K., Kohno Y., Minoguchi H., Kihara N., Sano Y., Yasuhara H.et al. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Chest. 121(3):2002;732-738.
9. Gong H. Jr., Linn W.S., Terrell S.L., Anderson K.R., Clark K.W. Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide. Chest. 119(2):2001;402-408.
10. Ihaku D., Cameron L., Suzuki M., Molet S., Martin J., Hamid Q. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5 expressing cells in Brown Norway rats. J. Allergy Clin. Immunol. 104(6):1999;1147-1154.
11. Pizzichini E., Leff J.A., Reis T.F., Hendeles L., Boulet L.P., Wei L.X.et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur. Respir. J. 14(1):1999;12-18.
12. DuBuske L.M. Mediator antagonists in the treatment of allergic disease. Allergy Asthma Proc. 22(5):2001;261-275.
13. Boyum A. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. 97:1968;77-89.
14. Babior B.M., Cohen H.J. Measurement of neutrophil function. Cline M.J. Leukocyte function. 1981;1-38 Livingstone, New York.
15. Micillo E., Bianco A., D'Auria D., Mazzarella G., Abbate G.F. Respiratory infections and asthma. Allergy. 55(Suppl. 61):2000;42-45.
16. Gern J.E. Viral and bacterial infections in the development and progression of asthma. J. Allergy Clin. Immunol. 105:2000;S497-S502.
17. Ferreira A., Williams Z., Donninger H., van Schalkwyk E.M., Bardin P.G. Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12. Respiration. 69(2):2002;136-142.
18. Message S.D., Johnston S.L. The immunology of virus infection in asthma. Eur. Respir. J. 18(6):2001;1013-1025.
19. Blasi F., Cosentini R., Tarsia P. Chlamydia pneumoniae respiratory infections. Curr. Opin. Infect. Dis. 13(2):2000;161-164.
20. Daian C.M., Wolff A.H., Bielory L. The role of atypical organisms in asthma. Allergy Asthma Proc. 21(2):2000;107-111.
21. Hirscmann J.V. Antibiotics for common respiratory tract infections in adults. Arch. Intern. Med. 162(3):2002;256-264.
22. Oehling A.G., Akdis C.A., Schapowal A., Blaser K., Schmitz M., Simon H.U. Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy. 52(2):1997;144-154.
23. Parnes S.M., Chuma A.V. Acute effects of antileukotriene on sinonasal polyposis and sinusitis. Ear Nose Throat J. 79(1):2000;18-20.
24. Schubert MS. Antileukotriene therapy for allergic fungal sinusitis 2001;108:466-467.
25. Wilson A.M., White P.S., Gardiner Q., Nassif R., Lipworth B.J. Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting. Rhinology. 39:2001;142-146.
26. Ng D.K., Law A.K., Chau K.W., Chan H.K. Use of montelukast in the treatment of early childhood wheezing from clinical experience with tree cases. Respirology. 5:2000;389-392.
27. Moran F.J., Puente L.F., Perez-Giraldo C., Hurtado C., Blanco M.T., Gomez-Garcia A.C. Effects of cefpirome in comparison with cefuroxime against human polymorphnuclear leucocytes in vitro. J. Antimicrob. Chemother. 33:1994;57-62.
28. Kadir T., Izzettin F.V., Cevikbas A., Johansson C.B., Clark P. In vitro effects of clarithromycin on human polymorphnuclear leukocyte functions. Chemotherapy. 46:2000;198-203.
29. Venezio F.R., DiVincenzo C.A. Effects of aminoglycoside antibiotics on polymorphnuclear leukocyte function in vivo. Antimicrob. Agents Chemother. 27:1985;712-714.
30. Mini E., Novelli A., Coronello M., Fallani S., Pesciullesi A., Periti P. In vitro effects of brodimoprim on human polymorphnuclear leukocyte functions. Preliminary results. J. Chemother. 5:1993;499-501.
31. Faden H., Hon J.J., Ogra P.L. In-vivo effects of clindamycin on neutrophil function, a preliminary report. J. Antimicrob. Chemother. 12(Suppl. C):1983;29-34.
32. Adalati R., Gurer U.S., Cevikbas A., Johansson C. In vitro effect of amikacin, imipenem, cefodizime, IFNalpha-2a alone and combinations of antibiotics with IFNalpha-2a on polymorphnuclear leukocyte functions in chronic hepatit patients. Chemotherapy. 47:2001;261-265.